Decision: Favourable

Decisions Table

Study Title:

A Prospective Open label single arm Post Market Clinical Follow-up trial of the FARAPULSE pulsed field ablation system in patients with paroxysmal Atrial fibrillation.

  • NREC Code:

    22-NREC-MD-022

  • Decision:

    Favourable

  • Meeting Date:

    18/08/2022

  • Study Type:

    MD application

  • Principal Investigator:

    Dr Gabor Szeplaki

  • PI Institution:

    Mater Private Hospital, Dublin

  • Sponsor:

    FARAPULSE, Inc

Scroll to Top